COLL
NASDAQ · Pharmaceuticals
Collegium Pharmaceutical Inc
$29.47
+0.36 (+1.24%)
Open$29.01
Previous Close$29.11
Day High$29.81
Day Low$28.01
52W High$50.79
52W Low$28.90
Volume—
Avg Volume502.6K
Market Cap937.01M
P/E Ratio12.50
EPS$1.88
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+63.4% upside
Current
$29.47
$29.47
Target
$48.15
$48.15
$33.48
$48.15 avg
$61.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 638.12M | 536.50M | 486.77M |
| Net Income | 51.40M | 38.89M | 68.71M |
| Profit Margin | 8.1% | 7.7% | 14.1% |
| EBITDA | 137.20M | 109.58M | 134.63M |
| Free Cash Flow | — | — | 97.48M |
| Rev Growth | +18.9% | +18.9% | +18.7% |
| Debt/Equity | 3.09 | 3.09 | 0.46 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |